|Day Low/High||3.75 / 4.33|
|52 Wk Low/High||2.55 / 26.95|
—Management to host webcast and conference call on Friday, April 28, 2017 at 8:45 a.m. ET—
Cempra, Tesaro and Editas Medicine were among the biotech stock movers in premarket trading on Tuesday.
—Company plans to resubmit MAA with additional data, in alignment with FDA strategy—
Cempra, Blueprint Medicines and Aralez Pharmaceuticals were among the biotech stock movers in premarket trading on Monday.
—Presentation time at Cowen and Company 37th Annual Health Care Conference on Monday, March 6 changed to 2:40 p.m. ET—
Cempra, Novavax and Ionis Pharmaceuticals were among the biotech stock movers in premarket trading on Tuesday.
BioCryst Pharmaceuticals, Sangamo Therapeutics and Cempra were among the biotech stock movers in premarket trading on Monday.
These four biotech stocks have been moving on some interesting news and clinical results.
Other movers include Incyte, Achillion and Inovio.
Management to host webcast and conference call on Tuesday, February 28, 2017 at 8:45 a.m. EST
Acorda was soaring ahead of the market open, thanks to positive late-stage clinical trial results for levodopa.
The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Cempra, Inc.
Glancy Prongay & Murray LLP ("GPM") reminds investors of the January 3, 2017 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased Cempra, Inc.
Stocks slumped for the second consecutive day as markets adjust to mixed economic data and the financial sector led the decline.
Stocks are volatile at midday Thursday and are turning mostly negative as markets adjust to mixed economic data and as the financial sector slumps.
Stocks were volatile Thursday as markets adjust to mixed economic data. Sears shares are seeing a boost while Cempra's stock plummets.
Stocks were mixed Thursday morning as markets adjusted to losses on Wednesday and investors received mixed economic data.
Management to host webcast and conference call today at 9:00 a.m. ET
The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Middle District of North Carolina on behalf of investors who purchased Cempra, Inc.
Investors in Cempra Inc saw new options become available this week, for the February 2017 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the CEMP options chain for the new February 2017 contracts and identified one put and one call contract of particular interest.